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and by using either the patient’s own
unaffected tissue or samples appropriately
matched to the patient population for
important risk factors. Statistical approa-
ches such as gene co-expression analysis
require larger sample sizes than can be
accommodated by laser-capture micro-
scopy, so further development and appli-
cation of methods that cope with and
exploit diverse cell populations within
a sample will be quite useful. RNA-seq
is now the technology of choice for
genomic studies, although microarray
will continue to be attractive in large
studies in which RNA-seq analysis is not
economically feasible. Li et al. (2014)
have illustrated the use of these
approaches and the data they present
will inform studies of psoriasis and the
fields of skin biology and immunology.
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An Unexpected Role: UVA-Induced
Release of Nitric Oxide from Skin May
Have Unexpected Health Benefits
Gary M. Halliday1 and Scott N. Byrne1,2
UVR has deleterious and beneficial effects on human health. In this issue, Liu et al.
(2014) show that UVA decreases blood pressure and increases blood flow and
heart rate in humans, which is beneficial to the cardiovascular system. This is likely
mediated by UVA causing release of nitric oxide (NO) from skin stores. This
mediator may have additional effects on human health.
Journal of Investigative Dermatology (2014) 134, 1791–1794. doi:10.1038/jid.2014.33
UVA radiation has beneficial effects on
the cardiovascular system
UVR from the sun causes considerable
damage to the skin, including photoa-
ging, the formation of skin cancer, and
suppression of adaptive immunity. UV
causes production of reactive oxygen
species (ROS) in the skin, resulting in
oxidative stress. It damages DNA, sub-
sequently fixing mutations if the cell
does not die or if the damage is not
repaired before cell division. UV-indu-
ced ROS also damage proteins and
lipids, altering cellular signaling and
other essential cellular functions. How-
ever, UV also has some health benefits,
as reviewed recently (Juzeniene et al.,
2011). Seasonal and latitudinal variat-
ions in cardiovascular disease have led
to suggestions that sunlight may be of
benefit for these diseases (Juzeniene
et al., 2011), but the evidence for this
has been inconclusive. There could
be multiple explanations other than
sunlight exposure for this association,
including nutrition and a more active
lifestyle associated with warmer
temperatures. This is an active area of
research likely to yield new and
interesting associations between UV
effects on the skin and human health.
Although this relationship between
sunlight exposure and cardiovascular
disease has often been linked to
vitamin D (Juzeniene et al., 2011), a
different mediator, nitric oxide (NO) has
been implicated by a new study in this
issue of JID. Liu et al. (2014) report that
UVA (320–400 nm) lowers blood
pressure, increases blood flow in the
forearm, and increases heart rate in
healthy human volunteers. The mag-
nitude of these effects was sufficient to
be of cardiovascular benefit and possibly
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to reduce the risk of stroke. These
changes were not associated with rises
in vitamin D levels, nor were they due to
an increase in either skin or core
temperature during the irradiation.
Controls irradiated through a metal foil
‘space blanket’ had similar rises is skin
and core temperature as the UVA-
irradiated group. There was a temporary
fall in blood pressure in the control
group, presumably owing to the
temperature increase, but this returned
to pre-irradiation levels at the end of the
sham irradiation. Blood pressure in
the UVA-irradiated group, however,
remained lower for up to 30 minutes
after irradiation. Contrasting with this,
heart rate fell slightly in the sham-
irradiation group, although it rose in the
UVA-irradiated group. These carefully
controlled human studies provide
compelling evidence that UVA
irradiation of the skin provides health
benefits to the cardiovascular system.
UVA-induced photolysis of NO stores in
the skin may mediate the changes in
blood pressure
The UVA-induced mediator responsible
for the lowering of blood pressure has
not been definitively identified but was
suggested to be NO (Liu et al., 2014).
NO is able to modulate blood pressure
and therefore seems to be a worthwhile
candidate to consider (Oplander and
Suschek, 2009). NO can be produced
enzymatically in the skin from a family
of NO synthases, some of which are
constitutively expressed and one of
which is inducible. There are also
chemical stores of NO in the skin,
including nitrite and others that have
not been fully characterized, which can
decompose to produce NO (Mowbray
et al., 2009). Forearm blood flow
remained elevated in UVA-irradiated
compared with sham-irradiated groups,
despite the presence of the NO synthase
inhibitor L-NG-monomethyl Arginine
(L-NMMA). Assuming that the blood
pressure and blood flow changes are
parts of the same response, and
although this cannot rule out a partial
role for NO synthase, these enzymes
do not appear to completely explain
the UVA-induced effects observed in
this study. Liu et al. (2014) therefore
propose UVA-induced photolysis of NO
stores in the skin to be the source of the
mediator. Evidence for this, although
indirect, seems plausible.
Previous studies have shown that
biologically significant chemical stores
of NO are present in the skin, which
include nitrite. NO can be liberated
from these stores by UVA irradiation
(Mowbray et al., 2009). In support of
their hypothesis, Liu et al. (2014) used a
NO-detecting fluorescent probe to show
that UVA induces the production of NO
in human epidermis with a time course
rapid enough to be consistent with
involvement in the effects on blood
pressure and blood flow. A failure of
L-NMMA to inhibit this rapid NO pro-
duction was consistent with the
inability of this drug to inhibit UVA
effects on blood flow. This suggests
that chemical stores were the source
of the UVA-liberated NO. UVA increa-
sed the blood levels of nitrite but
lowered the levels of nitrate, suggesting
that the increase in nitrite occurred
via conversion from nitrate. This is
consistent with nitrate being reduced
to nitrite, which can then liberate NO.
Although these changes appear to be
coordinated, further work is required to
determine the details and to prove a
direct causative role. Liu et al. (2014)
suggested that UVA causes photolysis of
a cutaneous store of NO, which is
released into the systemic circulation,
initiating these changes. This suggestion
is based on the rapidity of these
biochemical changes and their direct
observation of the L-NMMA-independent
production of NO in the epidermis.
Modeling showed that UVA photolysis
of NO stores in the skin could be
responsible for more than 80% of
blood NO, suggesting that this could
be primarily responsible for the seasonal
and latitudinal changes in circulating
NO and blood pressure.
The bad side of NO
Nitric oxide has ‘‘good’’ and ‘‘bad’’
sides (Oplander and Suschek, 2009). It
regulates a large number of biological
responses and can limit the conse-
quences of some damaging events, but
can also cause unwanted pathology.
NO can contribute to oxidative stress
when it combines with superoxide to
form peroxynitrite.
UVR can cause a range of different
forms of DNA damage, including cyclo-
butane pyrimidine dimers (CPDs) and
oxidation to produce, among other oxi-
dative products, 8-oxo-7,8-dihydro-20-
deoxyguanosine (8-oxodG). The NO
synthase inhibitor 1400 W enhanced
repair of UV-induced CPDs and
8-oxodG in human keratinocytes.
UV-induced peroxynitrite can result in
nitrosylated DNA damage, which may
slow the repair of other photolesions
such as CPDs or 8-oxodG. Alterna-
tively, peroxynitrite-mediated damage
to DNA repair proteins could be
responsible for these effects (Gordon-
Thomson et al., 2012). Although these
studies demonstrated this role for NO
produced from NO synthase, UVA-
induced photolysis of NO stores in
the skin would be expected to have
a similar effect in the presence of
superoxide.
Both UVB and UVA are immunosup-
pressive in humans. UVB instigates a
linear dose-responsive suppression of
immunity, at least up to doses that are
physiologically achievable without
causing extensive sunburn. In contrast,
UVA causes a bell-shaped dose
response (Halliday et al., 2012). UVA
doses received by humans during
normal daily activities contribute to
immunosuppression, whereas the UVA
doses that would be received by high
erythemal sunlight exposures do not
Clinical Implications
 UVA radiation has health benefits for cardiovascular disease.
 UVA radiation–induced release of nitric oxide (NO) from cutaneous stores
could affect the systemic vascular system.
 NO stores in the skin liberated by UVA are likely to have as yet unexplored
health consequences.
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appear to be immunosuppressive. The
reasons for this are intriguing, but the
action spectrum suggests ROS to be
involved. The peak UVA waveband
that causes immunosuppression is at
about 370 nm, which is a similar
wavelength dependency for formation
of ROS and oxidative damage to DNA.
It is therefore possible that ROS are
involved in UVA-induced immunosup-
pression. NO is also a mediator of
UVA immunosuppression. Inhibition of
NO synthase prevents UVA-induced
depletion of Langerhans cells from the
epidermis of mice, and also local UVA-
induced immunosuppression (Yuen
et al., 2002). Depletion of Langerhans
cells from the epidermis is one of the
cellular mechanisms by which UV
suppresses immunity to an antigen app-
lied locally to the UV-irradiated site.
NO has complex biological properties,
dependent on other interactive
mediators such as the presence of
superoxide to enable the formation of
peroxynitrite, which subsequently
causes oxidative damage, as opposed
to the multiple regulatory activities of
NO. It is possible that NO may be invol-
ved in the bell-shaped dose response
curve for UV-induced immunosuppre-
ssion, and that the relative production
of superoxide may dictate whether
or not UVA is immunosuppressive.
Limitations in the amount of cutaneous
NO stores available for liberation by
UVA, combined with increasing ROS
production may shift the balance bet-
ween these mediators at different UVA
doses, altering immunity. However, this
issue is not yet understood.
Considering that NO contributes
to UV-induced genetic damage and
immunosuppression, NO produced in
response to UVA, either via NO
synthase or photolytic cleavage of NO
stores in the skin, could contribute to
sunlight-induced carcinogenesis.
Can more good come from
UVA-induced photolysis of skin NO
stores?
The implications of this study by Liu
et al. (2014) are far reaching and extend
beyond the beneficial effects of UVA-
induced NO on cardiovascular disease.
Indeed, there is now convincing evide-
nce that exposure to the UV component
of sunlight protects humans from
developing a number of conditions,
including depressive seasonal affective
disorder, Crohn’s disease, inflammatory
bowel disease, and even colorectal
cancer. The so-called latitude gradient
effect is particularly strong for auto-
immune diseases including type 1
diabetes, Sjo¨gren’s syndrome, and
rheumatoid arthritis (Ponsonby et al.,
2005) (Juzeniene et al., 2011). How-
ever, it is central nervous system (CNS)-
targeted autoimmune diseases such as
multiple sclerosis (MS) that show the
most striking inverse correlation with
UV. Because MS patients tend to be
vitamin D deficient and relapse more
frequently during winter, many groups
are exploring the potential of vitamin D
supplements to prevent and/or treat MS.
However, similar to what Liu et al.
(2014) found in their study related to
cardiovascular disease, it is insufficient
exposure to sunlight and not necessarily
low vitamin D status per se that could
explain the latitude effect associated
with protection from these diseases
(Hart et al., 2011).
The study by Liu et al. (2014) there-
fore begs the question, could the UVA-
induced NO release from cutaneous
stores affect distant sites such as the
CNS or even modulate the development
of autoimmune diseases? A number of
recently published studies suggest this
could be the case. NO can act over long
distances to increase blood flow to the
brain, increasing oxygenation to this
tissue and affecting brain function.
There are conflicting reports that NO
can be both neuroprotective and neuro-
toxic depending on concentration
(Juzeniene et al., 2011). Initial obser-
vations in human MS patients found
elevated iNOS levels in brain lesions,
although no correlations were found
between MS disease and serum nitrate/
nitrite levels (Giovannoni et al., 1998).
Convincing evidence in experimental
autoimmune encephalomyelitis (EAE)
suggests that raising NO levels may be
protective in this animal model of CNS-
targeted autoimmunity (Xu et al., 2001).
Mice exposed to UVA and UVB
combined are also protected from EAE
in a vitamin D-independent manner
(Becklund et al., 2010). The precise
mechanism is not known, nor is it
clear whether the protective effects of
sunlight are UVA- or UVB-mediated.
The study by Liu et al. (2014) raises
the question whether UVA-induced NO
could be protective from MS and EAE,
or could provide other health benefits
arising from sun exposure.
Conclusions
The report by Liu et al. (2014) of UVA-
induced release of cutaneous NO
describes a hitherto unrecognized role
for this compound in reducing the risk
factors for cardiovascular disease.
Although this process could contribute
to UVA-induced immune suppression,
genetic damage, and carcinogenesis
it may also form the basis for under-
standing some of the benefits of
sunlight, including protection from
autoimmunity. This study has raised a
large number of questions that require
additional research.
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Opening a Niche for Therapy: Local
Lymphodepletion Helps the Immune
System to Fight Melanoma
Karsten Mahnke1, Alexander Skorokhod1, Stefan Grabbe2 and
Alexander H. Enk1
In this issue, Fujiwara et al. report that local ablation of CD4þ T cells in a murine
B16 melanoma model, together with concomitant activation of the immune
system by OX40L, leads to complete rejection of the melanomas. Rejection was
driven mainly by CD8þ T cells, which infiltrated the melanomas and secreted
sizeable amounts of IFN-g. However, CD8þ T-cell infiltration also caused the
recruitment of immunosuppressive myeloid-derived suppressor cells (MDSCs).
Although these cells did not prevent the rejection of the melanomas, in clinical
settings the long-term repopulation of tumors by MDSCs may counteract
successful treatment. Thus, local ablation of CD4þ leukocytes may improve
anti-melanoma therapies in humans, but at the same time MDSC levels in the
tumor cells have to be kept in check to ensure treatment success.
Journal of Investigative Dermatology (2014) 134, 1794–1796. doi:10.1038/jid.2014.100
Intratumoral injection of anti-CD4
antibodies removes suppressive cells
efficiently from melanomas
One of the main findings of the paper by
Fujiwara et al. (2014) is that removal of
intratumoral CD4þ T cells paves the
way for successful immunotherapy. At
first glance these results are unexpected,
as the protective role of the immune
cells, and in particular of T cells, has
been demonstrated many times in dif-
ferent tumor entities such as prostate,
colorectal, ovarian, and others. In addi-
tion, melanomas can harbor substantial
numbers of tumor-infiltrating leuko-
cytes, which battle melanoma growth
and render the melanoma susceptible to
other therapies. In this context, pioneer-
ing work reported by Rosenberg and
others in the late 1980s used ex vivo–
activated T cells to reduce tumor
burdens, and even to produce total
remissions in patients with melanomas
(Rosenberg et al., 1985). Thus, a pro-
tective role for T cells against melanoma
growth was established early on.
With the discovery of CD4þ regula-
tory T cells (Tregs), it became apparent
that T cells are not just protective ‘‘good
guys’’; rather, defined subpopulations of
leukocytes may also exert adverse effects
on immune responses against cancer
(Nishikawa and Sakaguchi, 2010). For
example, peripheral CD4þCD25þ Tregs
are able to suppress a variety of immune
reactions albeit by different means. They
are recruited into melanomas and can
even be newly generated within the
tumor environment. These naturally
occurring or induced Tregs are involved
substantially in creating an immuno-
suppressive environment that helps the
tumor to evade immunologic destruc-
tion. Therefore, several preclinical and
clinical studies have been performed to
deplete or to inactivate CD4þCD25þ
Tregs in tumor-bearing hosts and to
stimulate the remaining effector cells.
Indeed, by depleting Tregs with anti-
bodies specific for CD25 or by inactivat-
ing them with CTLA-4 antibodies, robust
antitumor immunity could be induced
in murine tumor models, as well as in
human trials (Peggs et al., 2006; Mahnke
et al., 2007). Along these lines, the article
by Fujiwara et al. (2014) shows that
intratumoral removal of CD4þ T cells,
in combination with a potent immuno-
stimulatory agent, i.e., OX40 ligand, is
able to cause rejection of B16 melanomas
in mice (Piconese et al., 2008;
Hirschhorn-Cymerman et al., 2009).
Interestingly, only this combinatorial
approach leads to the destruction of
the tumors. Neither CD4 ablation nor
OX40L stimulation alone was successful.
Thus, depletion of suppressive cells only
prepares the ‘‘soil’’ for successful immune
stimulation, but it does not provide
sufficient means to battle the tumor on
its own.
The use of anti-CD4 antibodies has
additional advantages over approaches
using anti-CD25 antibodies, which, in
fact, remove only CD4þCD25þ Tregs
and leave up to 50% of CD4þFoxP3þ
bona fide Tregs unaffected (Couper
et al., 2007). Other regulatory, active
CD4þ lymphocytes, such as IL-10-pro-
ducing Tr1 cells, as well as transforming
growth factor-b–secreting Th3 cells,
remain in the tumors. Therefore, by
applyng anti-CD4 antibodies for deple-
tion, presumably all suppressive CD4þ
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